FTV · Q2 2026 Earnings

Bullish

Fortive

Reported July 29, 2026

30-second summary

Fortive delivered Q2 revenue of $1.097B (+7.9% YoY, core +6.7%) and non-GAAP EPS of $0.74, beating consensus of $1.07B / $0.71 by 2.5% and 4.2% respectively — and, more importantly, coming in $0.04 above management's own "broadly similar to $0.70" Q2 FY2026 guide from last quarter. FY2026 adjusted EPS was raised $0.05 at both ends to $2.95–$3.05, ending three consecutive quarters of holding the range and formally invalidating the Q2–Q3 flatline thesis management planted in April. Core growth of 6.7% is running more than 2x the FY 2–3% guide with no revenue raise disclosed, meaning either H2 core decelerates sharply or another guidance raise is queued for Q3 FY2026.

Headline numbers

EPS

Q2 FY2026

$0.74

+4.2% vs est.

Revenue

Q2 FY2026

$1.10B

+7.9% YoY

+2.5% vs est.

Gross margin

Q2 FY2026

63.4%

Free cash flow

Q2 FY2026

$0.27B

Operating margin

Q2 FY2026

19.1%

Key financials

Q2 FY2026

Metric	Q2 FY2026	Q2 FY2025	YoY	Q1 FY2026	QoQ
Revenue	$1.10B	$1.02B	+8.0%	$1.07B	+2.6%
EPS	$0.74	$0.58	+27.6%	$0.70	+5.7%
Gross margin	63.4%	63.5%	-10bps	63.2%	+20bps
Operating margin	19.1%	16.7%	+240bps	17.9%	+120bps
Free cash flow	$0.27B	$0.18B	+50.6%	$0.19B	+39.7%

Guidance

Fortive raised FY2026 adjusted EPS guidance by $0.05 to $2.95–$3.05 on strong Q2 beat, with both revenue and EPS exceeding prior quarter expectations.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

Metric	Period	Prior guide	Actual	Δ	Result
Adjusted EPS	Q2 FY2026	~$0.70 (broadly similar to Q1)	$0.74	+$0.04 above guide	Beat
Revenue	Q2 FY2026	~$1.07 billion (Q1 baseline, Q2 expected comparable)	$1.097	+$0.027 billion above guide	Beat

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Adjusted EPS	FY2026	$2.90–$3.00	$2.95–$3.05	+$0.05 (both low and high end raised)	Raised

Segment KPIs

Q2 FY2026

Segment	Q2 FY2026	Q2 FY2025	YoY
Intelligent Operating Solutions	$0.758B	$0.697B	+8.8%
Advanced Healthcare Solutions	$0.339B	$0.32B	+5.9%

Other KPIs

Q2 FY2026

Segment	Q2 FY2026	Q2 FY2025	YoY
Adjusted EBITDA	$323.1M	—	—
Adjusted EBITDA Margin	29.5%	28.4%	—
Core Revenue Growth	6.7%	—	—
Intelligent Operating Solutions Adjusted EBITDA Margin	34.9%	—	—
Advanced Healthcare Solutions Adjusted EBITDA Margin	26.1%	26.9%	—
TTM Free Cash Flow	$1,044M	$0.939B	—
Share Repurchases (Q2)	~$200M	—	—
FY2026 Adjusted EPS Guidance (Raised)	$2.95–$3.05	—	—

Management tone

Q3 FY2025 anchor: Offensive growth pivot via FBS reinvestment → Q4 FY2025 anchor: Execution validation with forward conservatism → Q1 FY2026 anchor: Strategy validation across three quarters → Q2 FY2026 anchor: Deceleration script formally abandoned

No transcript was available for this quarter, so tone analysis is drawn from the press-release language and guidance-shift mechanics rather than prepared-remarks commentary.

Language shifted from "reaffirming with upper-half bias" to "raising with forward confidence" — the guidance posture inverted quarter over quarter. Q1 FY2026 held the range at $2.90–$3.00 with "trending upper half" framing, which was defensive; this quarter's press release states management is raising the FY range "reflecting our strong first-half performance and confidence in the trajectory of the business" and cites "significant shareholder value creation opportunity ahead of us." The shift from defensive reaffirmation to offensive raise, paired with the abandonment of the "Q2–Q3 broadly similar to $0.70" flatline guide, signals management now views the H1 execution as extrapolatable rather than a one-cycle beat to sandbag against.

The medium-term framework language is unchanged, but the tone around it moved from defensive to declarative. Q1 FY2026 management described "confidence continues to build" in the accelerator strategy after three quarters of execution; this quarter management asserts "significant shareholder value creation opportunity ahead of us" while continuing to reiterate confidence in the "medium-term financial framework." Same words on the framework, but the surrounding posture has moved from "we're building the case" to "the case is made." This is the most confident forward-looking language New Fortive has issued since the spin.

Answers to last quarter's watch list

Q2 FY2026 EPS vs. the "broadly similar to $0.70" guide — Q2 non-GAAP EPS came in at $0.74, $0.04 above the guide and 4.2% above $0.71 consensus. This confirms management was sandbagging in Q1; the deceleration model is invalidated. The FY raise of only $0.05 despite an H1 beat pace suggests management continues to bias conservative, but the "flatline" framing is now retired.

Resolved positively

AHS EBITDA margin — third consecutive sub-27% print would invalidate the "localized" thesis entirely — AHS Q2 FY2026 EBITDA margin came in at 26.1% (-80bps YoY, +40bps QoQ), the third consecutive print below 27%. While sequential improvement is directionally positive, the explicit YoY compression the press release calls out ("(80) bps") shows the segment is running at a structurally lower margin than management's earlier "firmly intact improvement path" framing implied.

Resolved negatively

Core growth deceleration into Q2 FY2026 — Q2 core growth 6.7%, +140bps above Q1 FY2026's 5.3% and more than 2x the FY 2–3% guide. H1 core is now running well above the FY range; H2 would need to average roughly 0% core growth to hit a 3% FY blend. Either the FY core guide is now materially conservative (the likely read given H1 delivery) or H2 contains a deceleration management has not disclosed.

Resolved positively

Net interest expense actuals — The press release did not disclose an updated FY interest expense guide. The $135M FY interest assumption from Q1 has not been revised in the release. Company didn't call out on the print.

Continue monitoring

Buyback pace and updated share count disclosure — Q2 FY2026 repurchases came in at ~$200M, materially below Q1 FY2026's ~$500M pace. No updated diluted share count guide was reintroduced. The Q1 buyback intensity was not sustained; whether this reflects price discipline or dry-powder preservation for M&A wasn't addressed in the release.

Continue monitoring

M&A pipeline activation — No bolt-on transaction was announced in Q2 FY2026. Management's Q1 FY2026 "pipeline being built" framing has not yet converted to a deal announcement. The step-down in buyback pace could be consistent with pipeline development, but no explicit signal was disclosed.

Continue monitoring

What to watch into next quarter

Q3 FY2026 EPS vs. the raised FY2026 range — H1 delivered $1.44; FY guide midpoint of $3.00 implies H2 of $1.56 ($0.78/quarter) — With Q2 at $0.74, watch whether Q3 lands at $0.76+ (confirming the raise is still conservative and a further FY raise is likely) or at $0.74 or below (implying management's Q3 caution has real content).

AHS EBITDA margin — fourth consecutive sub-27% print would formalize a structural margin reset — Watch whether Q3 FY2026 breaks above 27% (delayed but real recovery) or holds in the 25–26% band (the segment's new operating range, requiring a reset of the durability thesis).

Core growth print vs. the still-unchanged 2–3% FY guide — With H1 core running ~6%, watch whether management raises the FY core guide at Q3 FY2026 or continues to hold the range. Holding it while delivering another 5%+ core print would signal the H2 assumptions embed a specific deceleration event management hasn't articulated.

Buyback pace re-acceleration or M&A announcement — The ~$300M sequential step-down in buybacks between Q1 FY2026 and Q2 FY2026 needs a narrative. Watch for either a Q3 FY2026 bolt-on announcement (validating the pipeline-building language) or a Q3 FY2026 buyback re-acceleration (validating price discipline as the Q2 driver).

Net interest expense actuals and any refinancing disclosure — The $15M raise flagged in Q1 FY2026 has not been explained; watch for interest expense line item disclosure and any commentary on debt or rate assumptions.

Sources

Fortive Q2 FY2026 press release: https://www.sec.gov/Archives/edgar/data/1659166/000165916626000033/ftv-q2x2026xearningsxpress.htm
Fortive Q1 FY2026 Tapebrief brief (cross-quarter guidance, tone, and watch-list comparison).
Fortive Q4 FY2025, Q3 FY2025, and Q2 FY2025 Tapebrief briefs (multi-quarter narrative arc).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.